The role of APRIL and BAFF in lymphocyte activation

Current Opinion in Immunology

Volumn 17, Issue 3, 2005, Pages 282-289

  Schneider, Pascal ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; BAFF PROTEIN; CD23 ANTIGEN; CD40 LIGAND; COMPLEMENT COMPONENT C3D RECEPTOR; LYMPHOCYTE SURFACE MARKER; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; CELL SURVIVAL; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; EXPERIMENTAL MOUSE; GERMINAL CENTER; HOMEOSTASIS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; LIGAND BINDING; NONHUMAN; PLASMA CELL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TONSIL CELL;

ANIMALS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18844447818     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.04.005     Document Type: Review

References (61)

1. S.G. Hymowitz, D.R. Patel, H.J. Wallweber, S. Runyon, M. Yan, J. Yin, S.K. Shriver, N.C. Gordon, B. Pan, and N.J. Skelton Structures of APRIL-receptor complexes: Like BCMA, TACI employs only a single cysteine-rich domain for high-affinity ligand binding J Biol Chem 280 2005 7218 7227 For structure lovers! These APRIL-BCMA and APRIL-TACI structures complement our molecular understanding of ligand-receptor interactions within this subfamily (see also Liu et al. [7] and Kim et al. [9]).
2. D.R. Patel, H.J. Wallweber, J. Yin, S.K. Shriver, S.A. Marsters, N.C. Gordon, M.A. Starovasnik, and R.F. Kelley Engineering an APRIL-specific B cell maturation antigen J Biol Chem 279 2004 16727 16735
3. M. Pelletier, J.S. Thompson, F. Qian, S.A. Bixler, D. Gong, T. Cachero, K. Gilbride, E. Day, M. Zafari, and C. Benjamin Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF J Biol Chem 278 2003 33127 33133
4. J.S. Thompson, S.A. Bixler, F. Qian, K. Vora, M.L. Scott, T.G. Cachero, C. Hession, P. Schneider, I.D. Sizing, and C. Mullen BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF Science 293 2001 2108 2111
5. M. Yan, J.R. Brady, B. Chan, W.P. Lee, B. Hsu, S. Harless, M. Cancro, I.S. Grewal, and V.M. Dixit Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency Curr Biol 11 2001 1547 1552
6. P. Rennert, P. Schneider, T.G. Cachero, J. Thompson, L. Trabach, S. Hertig, N. Holler, F. Qian, C. Mullen, and K. Strauch A soluble form of BCMA, a receptor for the TNF family member APRIL, inhibits tumor cell growth J Exp Med 192 2000 1677 1684
7. Y. Liu, X. Hong, J. Kappler, L. Jiang, R. Zhang, L. Xu, C.H. Pan, W.E. Martin, R.C. Murphy, and H.B. Shu Ligand-receptor binding revealed by the TNF family member TALL-1 Nature 423 2003 49 56
8. J.L. Bodmer, P. Schneider, and J. Tschopp The molecular architecture of the TNF superfamily Trends Biochem Sci 27 2002 19 26
9. H.M. Kim, K.S. Yu, M.E. Lee, D.R. Shin, Y.S. Kim, S.G. Paik, O.J. Yoo, H. Lee, and J.O. Lee Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation Nat Struct Biol 10 2003 342 348
10. N. Kayagaki, M. Yan, D. Seshasayee, H. Wang, W. Lee, D.M. French, I.S. Grewal, A.G. Cochran, N.C. Gordon, and J. Yin BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2 Immunity 17 2002 515 524
11. B. Pradet-Balade, J.P. Medema, M. Lopez-Fraga, J.C. Lozano, G.M. Kolfschoten, A. Picard, A.C. Martinez, J.A. Garcia-Sanz, and M. Hahne An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein EMBO J 21 2002 5711 5720
12. A.L. Gavin, D. Ait-Azzouzene, C.F. Ware, and D. Nemazee DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF J Biol Chem 278 2003 38220 38228
13. P.M. Steed, M.G. Tansey, J. Zalevsky, E.A. Zhukovsky, J.R. Desjarlais, D.E. Szymkowski, C. Abbott, D. Carmichael, C. Chan, and L. Cherry Inactivation of TNF signaling by rationally designed dominant-negative TNF variants Science 301 2003 1895 1898
14. V. Roschke, S. Sosnovtseva, C.D. Ward, J.S. Hong, R. Smith, V. Albert, W. Stohl, K.P. Baker, S. Ullrich, and B. Nardelli BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases J Immunol 169 2002 4314 4321
15. Y. Liu, L. Xu, N. Opalka, J. Kappler, H.B. Shu, and G. Zhang Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands Cell 108 2002 383 394
16. L. Gorelik, K. Gilbride, M. Dobles, S.L. Kalled, D. Zandman, and M.L. Scott Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells J Exp Med 198 2003 937 945 The first demonstration that the bulk of BAFF involved in maintenance of the peripheral B cell pool is not produced by myeloid cells.
17. R. Lesley, Y. Xu, S.L. Kalled, D.M. Hess, S.R. Schwab, H.B. Shu, and J.G. Cyster Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF Immunity 20 2004 441 453 Together with Thien et al. [26], these authors show that a physiological shortage of BAFF enables the maintenance of a peripheral B cell pool essentially devoid of autoreactive cells.
18. M. Krumbholz, D. Theil, T. Derfuss, A. Rosenwald, F. Schrader, C.M. Monoranu, S.L. Kalled, D.M. Hess, B. Serafini, and F. Aloisi BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma J Exp Med 2005
19. F. Lavie, C. Miceli-Richard, J. Quillard, S. Roux, P. Leclerc, and X. Mariette Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome J Pathol 202 2004 496 502
20. J. Ohata, N.J. Zvaifler, M. Nishio, D.L. Boyle, S.L. Kalled, D.A. Carson, and T.J. Kipps Fibroblast-Like Synoviocytes of Mesenchymal Origin Express Functional B Cell-Activating Factor of the TNF Family in Response to Proinflammatory Cytokines J Immunol 174 2005 864 870
21. A. Craxton, D. Magaletti, E.J. Ryan, and E.A. Clark Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF Blood 101 2003 4464 4471
22. P. Scapini, A. Carletto, B. Nardelli, F. Calzetti, V. Roschke, F. Merigo, N. Tamassia, S. Pieropan, D. Biasi, and A. Sbarbati Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases Blood 105 2005 830 837
23. M.J. Walmsley, S.K. Ooi, L.F. Reynolds, S.H. Smith, S. Ruf, A. Mathiot, L. Vanes, D.A. Williams, M.P. Cancro, and V.L. Tybulewicz Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling Science 302 2003 459 462
24. S.H. Smith, and M.P. Cancro Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors J Immunol 170 2003 5820 5823 B cell co-stimulation by BAFF (also called BLyS) is the result of increased survival rather than stimulation of cycling.
25. T. Hanada, H. Yoshida, S. Kato, K. Tanaka, K. Masutani, J. Tsukada, Y. Nomura, H. Mimata, M. Kubo, and A. Yoshimura Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity Immunity 19 2003 437 450
26. M. Thien, T.G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches Immunity 20 2004 785 798
27. D. Avery, S.L. Kalled, J.I. Ellyard, M. Thien, R. Brink, F. Mackay, P.D. Hodgkin, and S.G. Tangye BAFF selectively enhances the survival and effector function of CD38+ plasmablasts geerated from activated human memory B cells J Clin Invest 112 2003 286 297
28. B.P. O'Connor, V.S. Raman, L.D. Erickson, W.J. Cook, L.K. Weaver, C. Ahonen, L.L. Lin, G.T. Mantchev, R.J. Bram, and R.J. Noelle BCMA is essential for the survival of long-lived bone marrow plasma cells J Exp Med 199 2004 91 98 The authors describe a physiological role for BCMA.
29. J. Moreaux, E. Legouffe, E. Jourdan, P. Quittet, T. Reme, C. Lugagne, P. Moine, J.F. Rossi, B. Klein, and K. Tarte BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone Blood 103 2004 3148 3157
30. A.J. Novak, J.R. Darce, B.K. Arendt, B. Harder, K. Henderson, W. Kindsvogel, J.A. Gross, P.R. Greipp, and D.F. Jelinek Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival Blood 103 2004 689 694
31. B. He, A. Chadburn, E. Jou, E.J. Schattner, D.M. Knowles, and A. Cerutti Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL J Immunol 172 2004 3268 3279
32. M. Ramanujam, X. Wang, W. Huang, L. Schiffer, C. Grimaldi, A. Akkerman, B. Diamond, M.P. Madaio, and A. Davidson Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus J Immunol 173 2004 3524 3534 The authors demonstrate that memory B cells can persist despite BAFF and APRIL depletion.
33. B. Schiemann, J.L. Gommerman, K. Vora, T.G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M.L. Scott An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway Science 293 2001 2111 2114
34. J.A. Gross, S.R. Dillon, S. Mudri, J. Johnston, A. Littau, R. Roque, M. Rixon, O. Schou, K.P. Foley, and H. Haugen TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS Immunity 15 2001 289 302
35. S. Shulga-Morskaya, M. Dobles, M.E. Walsh, L.G. Ng, F. MacKay, S.P. Rao, S.L. Kalled, and M.L. Scott B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation J Immunol 173 2004 2331 2341 Together with [40], these authors define the role of BAFF-R and other receptors in mediating several BAFF actions.
36. L. Gorelik, A.H. Cutler, G. Thill, S.D. Miklasz, D.E. Shea, C. Ambrose, S.A. Bixler, L. Su, M.L. Scott, and S.L. Kalled Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function J Immunol 172 2004 762 766
37. M. Hikida, S. Johmura, A. Hashimoto, M. Takezaki, and T. Kurosaki Coupling between B cell receptor and phospholipase C-gamma2 is essential for mature B cell development J Exp Med 198 2003 581 589
38. D. Seshasayee, P. Valdez, M. Yan, V.M. Dixit, D. Tumas, and I.S. Grewal Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor Immunity 18 2003 279 288
39. L.G. Ng, A.P. Sutherland, R. Newton, F. Qian, T.G. Cachero, M.L. Scott, J.S. Thompson, J. Wheway, T. Chtanova, and J. Groom B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells J Immunol 173 2004 807 817 This is a study of receptor expression on various human and mouse B and T cell subsets.
40. Y. Sasaki, S. Casola, J.L. Kutok, K. Rajewsky, and M. Schmidt-Supprian TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology J Immunol 173 2004 2245 2252 Together with Shulga-Morskaya et al. [35], these authors define the role of BAFF-R and other receptors in mediating several BAFF actions.
41. A. Tardivel, A. Tinel, S. Lens, Q.G. Steiner, E. Sauberli, A. Wilson, F. Mackay, A.G. Rolink, F. Beermann, and J. Tschopp The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF Eur J Immunol 34 2004 509 518
42. Z.S. Rahman, S.P. Rao, S.L. Kalled, and T. Manser Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice J Exp Med 198 2003 1157 1169
43. K.A. Vora, L.C. Wang, S.P. Rao, Z.Y. Liu, G.R. Majeau, A.H. Cutler, P.S. Hochman, M.L. Scott, and S.L. Kalled Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function J Immunol 171 2003 547 551
44. G.U. von Bulow, J.M. van Deursen, and R.J. Bram Regulation of the T-independent humoral response by TACI Immunity 14 2001 573 582
45. E. Castigli, S. Scott, F. Dedeoglu, P. Bryce, H. Jabara, A.K. Bhan, E. Mizoguchi, and R.S. Geha Impaired IgA class switching in APRIL-deficient mice Proc Natl Acad Sci USA 101 2004 3903 3908
46. L. Planelles, C.E. Carvalho-Pinto, G. Hardenberg, S. Smaniotto, W. Savino, R. Gomez-Caro, M. Alvarez-Mon, J. de Jong, E. Eldering, and A.C. Martinez APRIL promotes B-1 cell-associated neoplasm Cancer Cell 6 2004 399 408
47. M. Balazs, F. Martin, T. Zhou, and J. Kearney Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses Immunity 17 2002 341 352
48. M.B. Litinskiy, B. Nardelli, D.M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL Nat Immunol 3 2002 822 829
49. B. He, N. Raab-Traub, P. Casali, and A. Cerutti EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching J Immunol 171 2003 5215 5224
50. E. Castigli, S.A. Wilson, S. Scott, F. Dedeoglu, S. Xu, K.P. Lam, R.J. Bram, H. Jabara, and R.S. Geha TACI and BAFF-R mediate isotype switching in B cells J Exp Med 201 2005 35 39 This study explores overlapping, but not redundant, roles of BAFF-R and TACI in CD40-independent antibody isotype switch.
51. B. Huard, L. Arlettaz, C. Ambrose, V. Kindler, D. Mauri, E. Roosnek, J. Tschopp, P. Schneider, and L.E. French BAFF production by antigen-presenting cells provides T cell co-stimulation Int Immunol 16 2004 467 475
52. B. Huard, P. Schneider, D. Mauri, J. Tschopp, and L.E. French T cell costimulation by the TNF ligand BAFF J Immunol 167 2001 6225 6231
53. Q. Ye, L. Wang, A.D. Wells, R. Tao, R. Han, A. Davidson, M.L. Scott, and W.W. Hancock BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses Eur J Immunol 34 2004 2750 2759 This is the first in vivo demonstration of a functional role of BAFF-R in T-cell activation.
54. S. Moir, A. Malaspina, O.K. Pickeral, E.T. Donoghue, J. Vasquez, N.J. Miller, S.R. Krishnan, M.A. Planta, J.F. Turney, and J.S. Justement Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily J Exp Med 200 2004 587 599
55. E. Varfolomeev, F. Kischkel, F. Martin, D. Seshasayee, H. Wang, D. Lawrence, C. Olsson, L. Tom, S. Erickson, and D. French APRIL-deficient mice have normal immune system development Mol Cell Biol 24 2004 997 1006
56. I.J. Amanna, J.P. Dingwall, and C.E. Hayes Enforced bcl-xL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice J Immunol 170 2003 4593 4600
57. M. Yan, H. Wang, B. Chan, M. Roose-Girma, S. Erickson, T. Baker, D. Tumas, I.S. Grewal, and V.M. Dixit Activation and accumulation of B cells in TACI-deficient mice Nat Immunol 2 2001 638 643
58. S. Xu, and K.P. Lam B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses Mol Cell Biol 21 2001 4067 4074
59. D.J. Miller, K.D. Hanson, J.A. Carman, and C.E. Hayes A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice Eur J Immunol 22 1992 373 379
60. V.M. Lentz, C.E. Hayes, and M.P. Cancro Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice J Immunol 160 1998 3743 3747
61. Ingold K, Zumsteg A, Tardivel A, Huard B, Steiner Q-G, Cachero T, Qian F, Gorelik L, Kalled SL, Acha-Orbea H et al.: Identification of proteoglycans as APRIL-specific binding partners. J Exp Med 2005, in press.